CClinicalTrials.gg
CompletedNCT02461251ROTEM-PPHUpdated Jan 29, 2020

Thromboelastometry-guided Treatment Protocol Versus Standard Care of Major Haemorrhage in Obstetric Patients

An interventional study of Rotational Thromboelastometry (ROTEM) in Obstetric Labor Complications and Hemorrhage, sponsored by Tampere University Hospital. Completed at 1 site in Finland. Open to female participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2020-01-29.

Sponsored by Tampere University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
59
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
Female
01

Study summary

This is a prospective, randomized and controlled study to find out if a rotational thromboelastometry(ROTEM) guided treatment protocol reduces the need for blood transfusions in major obstetric haemorrhage compared to standard care of clinical decision making, conventional coagulation tests and massive transfusion protocol. Secondary aim is to find out if ROTEM can predict the incidence of thromboembolic events in this patient group.

Read the detailed description

A comparison of two different treatment protocols is made in patients suffering major obstetric haemorrhage: those who after a normal delivery are bleeding more than 1000 ml and are in need of surgical intervention to control the bleeding and those in cesarean section with ongoing bleeding of more than 1000 ml. Patients are randomized in to two groups: the control group(n=30) will be treated according to a protocol based on clinical decision making, standard coagulation tests and massive transfusion packages of blood products(1:1:1), if needed. This is referred as 'Standard care' in this hospital. The intervention group(n=30) will be treated according to a rotational thromboelastometry guided protocol, and massive transfusion packages, if needed. The study is powered to detect a reduction of one unit in red blood cell transfusion. Blood product, fibrinogen concentrate, prothrombin complex concentrate usage and total amount of blood loss will be compared, and the number of transfusion related side effects and thromboembolic events 30 days after the bleeding will be recorded.

02

Conditions studied

  • Obstetric Labor Complications
  • Hemorrhage

Keywords

  • Thromboelastometry
  • Obstetric Hemorrhage
  • Blood Component Transfusion
03

In context

Obstetric Labor Complications

89 studies on the registry are indexed under Obstetric Labor Complications; 25 are open to participants now.

This study's enrollment of 59 is below the median of 150 across 63 interventional studies indexed under Obstetric Labor Complications.

Browse Obstetric Labor Complications studies →

Lead sponsor

Tampere University Hospital is the lead sponsor of 209 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Age over 18
  • Severe post-partum haemorrhage ie. active bleeding of more than 1000ml within 24 hours after vaginal delivery or cesarean section
  • Informed consent (after randomization)

Exclusion criteria

Exclusion Criteria:

  • Known hemophilia or von Willebrand's disease
  • Unacceptance of allogeneic blood products(Jehovah's witnesses)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
59 participants (actual)

Study arms

  • Experimental
    Rotational thromboelastometry (ROTEM)

    Rotational thromboelastometry results are used to guide the treatment of major obstetric hemorrhage, eg. administration of prothrombin complex concentrate, fresh-frozen plasma, fibrinogen concentrate or platelets. In case of massive hemorrhage, "shock packs" of blood products in 1:1:1 ratio are administered.

    Device: Rotational Thromboelastometry (ROTEM)

  • No intervention
    Standard care

    Patients are treated according to clinical decision making and conventional coagulation tests, and in case of massive hemorrhage, "shock packs" are administered.

Interventions

  • DeviceRotational Thromboelastometry (ROTEM)

    A Point-of-care blood coagulation test tool is used to guide the treatment of major obstetric bleeding.

06

What researchers measure

Primary outcomes

  1. Reduction in blood transfusions

    Time frame: 24 h

Secondary outcomes

  1. Reduction of transfusion related side-effects

    Time frame: 30 days

  2. Number of thromboembolic events

    Time frame: 30 days

07

Study locations

1 site
  • Tampere University Hospital
    Tampere, 33560, Finland
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 29, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02461251
Lead sponsor
Tampere University Hospital
Responsible party
Sponsor
First posted
Jun 3, 2015
Start date
Jan 2016
Primary completion
Jan 2020
Completion
Jan 2020
Last update
Jan 29, 2020

Study contacts

Anne Kuitunen, MD, PhD
study director · Tampere University Hospital
Samuli Jokinen, MD
principal investigator · Tampere University Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion